Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  HIV Infection

  Free Subscription


11.08.2025

11 AIDS
4 AIDS Res Hum Retroviruses
1 BMC Cancer
1 BMC Neurol
2 Clin Infect Dis
3 HIV Med
2 Int J Cancer
1 Int J Dermatol
10 J Acquir Immune Defic Syndr
1 J Clin Invest
1 J Infect Dis
2 J Med Virol
1 J Virol
5 PLoS One
2 PLoS Pathog


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. MENDES DE LEON KF, Nieuwkerk PT, Lemkes BA, Geerlings SE, et al
    Preferences for long-acting treatment among people with HIV: a discrete choice experiment.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004314.
    PubMed         Abstract available

  2. IRIARTE E, Jones R, Wang CX, Hall CDX, et al
    Gait speed and neurocognition among older people with and without HIV.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004312.
    PubMed         Abstract available

  3. THOME B, Pacola DP, Negra MD, Durigon GS, et al
    Persistent immunological repercussions of late antiretroviral initiation in children living with HIV.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004311.
    PubMed         Abstract available

  4. MASCARELL P, Gutierrez-Ortiz de la Tabla A, Ledesma C, Fernandez-Gonzalez M, et al
    A decade of anal cancer screening in the context of HIV care: feasibility, acceptability, and long-term retention.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004313.
    PubMed         Abstract available

  5. D'AMICO R, Han K, Min S, Demoor R, et al
    Subcutaneous injections of cabotegravir + rilpivirine long-acting in virally suppressed adults with HIV-1.
    AIDS. 2025 Aug 8. doi: 10.1097/QAD.0000000000004310.
    PubMed         Abstract available

  6. JEENA L, Ferrand RA, Simms V, Kahari C, et al
    Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe: Erratum.
    AIDS. 2025;39:1674-1675.
    PubMed        

  7. ANTWI S, Yang H, Enimil A, Martyn-Dickens C, et al
    Tenofovir diphosphate concentrations in dried blood spots predict future HIV suppression but not virologic failure in adolescents with HIV.
    AIDS. 2025;39:1668-1671.
    PubMed         Abstract available

  8. ERLY S, Troupe D, Capizzi J, Amiya R, et al
    Increase in heterosexual transmission of HIV in international Pacific Northwest region (United States and Canada).
    AIDS. 2025;39:1666-1668.
    PubMed         Abstract available

  9. RAHIM FO, Nguyen NT, Chen JK, Mahatara EV, et al
    A rollback on PEPFAR will have far-reaching consequences in global health.
    AIDS. 2025;39:1663-1665.
    PubMed        

  10. EGAN JE, Hillier SL, Avery AK, Friedman MR, et al
    The great mismatch: unfulfilled promise of biomedical HIV prevention.
    AIDS. 2025;39:1658-1660.
    PubMed        

  11. BEYRER C, Ratevosian J, Gelderblom H, Rosenberg NE, et al
    The HIV/AIDS pandemic: where are we now?
    AIDS. 2025;39:1497-1504.
    PubMed         Abstract available


    AIDS Res Hum Retroviruses

  12. DUPNIK KM, Dorvil N, Ward M, Rivera V, et al
    Histoplasma capsulatum Not Detected in People with HIV and Systemic Symptoms in Port-au-Prince, Haiti.
    AIDS Res Hum Retroviruses. 2025 Aug 1. doi: 10.1177/08892229251365925.
    PubMed         Abstract available

  13. LI R, Lu Y, Yang L, Long X, et al
    Analysis of Factors Influencing Immunological Failure in Elderly People Living with HIV Undergoing Antiretroviral Therapy: A LASSO-Logistic Regression Approach.
    AIDS Res Hum Retroviruses. 2025 Aug 6. doi: 10.1177/08892229251365583.
    PubMed         Abstract available

  14. CORDIE A, Kamel AM, Mohamed R, Samir S, et al
    CD4 Discordance as a Predictor of Liver Fibrosis in People Coinfected with Human Immune Deficiency Virus/Hepatitis C Virus: A Cross-Sectional Study.
    AIDS Res Hum Retroviruses. 2025 Aug 6. doi: 10.1177/08892229251365670.
    PubMed         Abstract available

  15. ALAVIAN N, Burns CM, Jenks JD, Hung F, et al
    Promoting Re-engagement in HIV Care after Emergency Department Visit by Leveraging Clinical Informatics at a Southern Academic Medical Center.
    AIDS Res Hum Retroviruses. 2025 Aug 6. doi: 10.1177/08892229251365260.
    PubMed         Abstract available


    BMC Cancer

  16. DONA MG, Paolini F, Benevolo M, Rollo F, et al
    Detection and significance of HPV16 E5-specific productive transcripts in oropharyngeal carcinoma.
    BMC Cancer. 2025;25:1274.
    PubMed         Abstract available


    BMC Neurol

  17. VANCE DE, Lang L, Maki PM, Yu D, et al
    Cognitive predictors of everyday functioning in women with HIV: findings from the women's interagency HIV study.
    BMC Neurol. 2025;25:317.
    PubMed         Abstract available


    Clin Infect Dis

  18. PEI PP, Jones M, Hu R, Chen W, et al
    Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US.
    Clin Infect Dis. 2025 Aug 4:ciaf428. doi: 10.1093.
    PubMed         Abstract available

  19. DRUMEL T, Sourice J, Allavena C, Rodallec A, et al
    Kinetics of non-nucleoside reverse transcriptase inhibitor resistance-associated mutations in HIV-1 proviral cellular reservoirs in NNRTI-experienced persons.
    Clin Infect Dis. 2025 Aug 4:ciaf430. doi: 10.1093.
    PubMed         Abstract available


    HIV Med

  20. ROSEN C, Gill MJ, Fujiwara E, Krentz H, et al
    Changing prevalence and risk factors for Toxoplasma gondii seropositivity and disease in persons with HIV at the Southern Alberta Clinic since 1985.
    HIV Med. 2025 Aug 4. doi: 10.1111/hiv.70093.
    PubMed         Abstract available

  21. NDEGE R, Okuma J, Kivuma B, Magnolini R, et al
    Stigma, depression and pillbox return among adults living with HIV in rural Tanzania: A prospective cohort study.
    HIV Med. 2025 Aug 5. doi: 10.1111/hiv.70090.
    PubMed         Abstract available

  22. BEHRENS GMN, Assoumou L, De Wit S, MacDonald R, et al
    Morbidity and risk factors of COVID-19 in people with HIV-1 in Europe: A combined observational cohort and nested case-control study.
    HIV Med. 2025 Aug 7. doi: 10.1111/hiv.70094.
    PubMed         Abstract available


    Int J Cancer

  23. LOPES-ARAUJO HF, Guimaraes RL, Carvalho-Silva WHV
    Correlations between new HIV infections and hospital admissions for non-Hodgkin lymphoma in Brazil.
    Int J Cancer. 2025 Aug 6. doi: 10.1002/ijc.70076.
    PubMed         Abstract available

  24. ROZEMEIJER K, Dias Goncalves Lima F, Kuyvenhoven EJ, de Vries HJC, et al
    Swab-based anal cancer screening in men living with HIV: Projected outcomes for different screening algorithms.
    Int J Cancer. 2025 Aug 5. doi: 10.1002/ijc.70046.
    PubMed         Abstract available


    Int J Dermatol

  25. ISAACS T, Jacobs T, Whitaker D, Visser W, et al
    Sun Protection Advice for the South African Population for the Prevention and Management of Skin Diseases.
    Int J Dermatol. 2025 Aug 4. doi: 10.1111/ijd.17994.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  26. NUTT CT, Muyindike WR, Nanfuka V, Komukama N, et al
    Factors Associated with Incomplete Adherence to Dolutegravir-Based Antiretroviral Therapy in Southwestern Uganda.
    J Acquir Immune Defic Syndr. 2025 Aug 4. doi: 10.1097/QAI.0000000000003735.
    PubMed         Abstract available

  27. HIGGINS N, Patel N, Solso S, Dullano C, et al
    Relationship between Opioid Use, Depression and Quality of Life among Persons with HIV at End of Life.
    J Acquir Immune Defic Syndr. 2025 Aug 4. doi: 10.1097/QAI.0000000000003737.
    PubMed        

  28. NJUGUNA I, Maleche-Obimbo E, Mugo C, Begnel ER, et al
    Herpesvirus viremia, ART response, and growth recovery in Kenyan children starting antiretroviral therapy in hospital.
    J Acquir Immune Defic Syndr. 2025 Aug 7. doi: 10.1097/QAI.0000000000003741.
    PubMed         Abstract available

  29. BOOPATHY AV, D'Antoni ML, Andreatta K, Chang S, et al
    Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Participants with Preexisting K65R/N in HIV-1 in Phase 2/3/3b Clinical Trials.
    J Acquir Immune Defic Syndr. 2025 Aug 8. doi: 10.1097/QAI.0000000000003742.
    PubMed         Abstract available

  30. DZOMBA A, Shumba K, Nattey C, Lauren E, et al
    HIV patient treatment adherence trajectories in first 24-months post-ART initiation among adults: an electronic health records cohort from South Africa.
    J Acquir Immune Defic Syndr. 2025 Aug 8. doi: 10.1097/QAI.0000000000003736.
    PubMed         Abstract available

  31. PALOMARES M, Shade SB, Pollack L, Zand P, et al
    Enthusiasm for Participation in a Novel, At-Home Delivery Model for Injectable HIV Treatment among People with HIV.
    J Acquir Immune Defic Syndr. 2025 Aug 8. doi: 10.1097/QAI.0000000000003743.
    PubMed        

  32. MORGAN E, Punches B, Failla M
    Self-Reported Diagnosis of Autism Is Associated With a Lower Likelihood of HIV Testing.
    J Acquir Immune Defic Syndr. 2024;97:e6-e9.
    PubMed         Abstract available

  33. MATONE M, Piscaglia M, Giacomelli A, Moschese D, et al
    Brief Report: Switching to Long-Acting CAB/RPV: Data From an Italian Monocentric Cohort.
    J Acquir Immune Defic Syndr. 2024;97:e1-e5.
    PubMed         Abstract available

  34. MAYER C, Agbobli-Nuwoaty SE, Li J, Carlson K, et al
    Brief Report: Unmet Need for Solid Organ Transplantation Among People With HIV and End-Stage Kidney or Liver Disease: A Brief Report From the HIV Outpatient Study, 2009-2023.
    J Acquir Immune Defic Syndr. 2024;97:397-401.
    PubMed         Abstract available

  35. WANG Z, Patterson W, Rajulu DT
    Brief Report: Aging With HIV: An Epidemiological Profile of Persons With Diagnosed HIV Aged 50 Years and Older in New York State, 2012-2021.
    J Acquir Immune Defic Syndr. 2024;97:353-356.
    PubMed         Abstract available


    J Clin Invest

  36. OMOLE TE, McKinnon LR
    Integrin alpha4beta7 as a predictor of HIV acquisition: one thread in a complex tapestry.
    J Clin Invest. 2025;135:e195258.
    PubMed         Abstract available


    J Infect Dis

  37. SAMANDARI T, Achola M, Hutter JN, Mboya G, et al
    Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults.
    J Infect Dis. 2025 Aug 2:jiaf398. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  38. SHRESTHA P, Treco EN, Davis DA, Yarchoan R, et al
    Novel Cereblon-Binding Immunomodulators Have Increased Potency Against Gammaherpesvirus- Associated Lymphomas In Vitro.
    J Med Virol. 2025;97:e70537.
    PubMed         Abstract available

  39. LI F, Zhao W, Liu H, Niu Y, et al
    Single-Cell Omics Analysis Reveals Immunological Dysregulation in COVID-19 and HIV: Identifying a Shared Abnormality of B Cell Activation via the Unfolded Protein Response and Diagnostic Biomarkers Using Machine Learning Algorithms.
    J Med Virol. 2025;97:e70538.
    PubMed         Abstract available


    J Virol

  40. MUELLER AL, Lamcaj S, Garforth S, Hiner C, et al
    T-cell receptor/CD28-targeted immunotherapeutics selectively drive naive T-cell expansion to generate functional HIV-specific responses.
    J Virol. 2025 Aug 5:e0018825. doi: 10.1128/jvi.00188.
    PubMed         Abstract available


    PLoS One

  41. GUGGILLA V, Pacheco JA, Carvalho AM, Whitmer GR, et al
    Immunosuppression variably impacts outcomes for patients hospitalized with COVID-19: A retrospective cohort study.
    PLoS One. 2025;20:e0330110.
    PubMed         Abstract available

  42. BLEICHRODT A, Phan A, Luo R, Kirpich A, et al
    StatModPredict: A user-friendly R-Shiny interface for fitting and forecasting with statistical models.
    PLoS One. 2025;20:e0329791.
    PubMed         Abstract available

  43. NURZHIGITOV N, Gustafson D, Nugmanova Z, Denebayeva A, et al
    Sociodemographic and behavioral characteristics of older people with HIV in Almaty City, Kazakhstan: A cross-sectional study.
    PLoS One. 2025;20:e0328821.
    PubMed         Abstract available

  44. KAYINDA F, Awor P, Mahaba T, Muganzi AM, et al
    Prevalence of HIV drug resistance, its correlates and common mutations among people living with HIV failing on ART in northern Uganda: A cross-sectional study.
    PLoS One. 2025;20:e0320623.
    PubMed         Abstract available

  45. ALHAMAD T, Younes S, El Chaar D, Nizamuddin PB, et al
    Comprehensive performance evaluation of four chemiluminescence immunoassays for detecting vitamin D deficiency across diverse clinical conditions.
    PLoS One. 2025;20:e0329796.
    PubMed         Abstract available


    PLoS Pathog

  46. LI G, Ma J, Yu H, Tsahouridis O, et al
    CD24-Fc resolves inflammation and enhances anti-HIV CD8 T cells with polyfunctionality during HIV-1 infection under ART.
    PLoS Pathog. 2025;21:e1012826.
    PubMed         Abstract available

  47. SERWIN K, Mielczak K, Urbanska A, Aksak-Was B, et al
    Comparison of HIV-1 A6 dispersal dynamics in Poland before and after the war in Ukraine.
    PLoS Pathog. 2025;21:e1013369.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.